Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,070,816
  • Shares Outstanding, K 49,215
  • Annual Sales, $ 4,050 M
  • Annual Income, $ 22,200 K
  • EBIT $ 555 M
  • EBITDA $ 1,132 M
  • 60-Month Beta 1.63
  • Price/Sales 2.24
  • Price/Cash Flow 8.48
  • Price/Book 2.66

Options Overview Details

View History
  • Implied Volatility 39.91% (+0.19%)
  • Historical Volatility 37.33%
  • IV Percentile 30%
  • IV Rank 14.22%
  • IV High 86.39% on 04/11/25
  • IV Low 32.21% on 06/18/25
  • Expected Move (DTE 11) 10.12 (5.37%)
  • Put/Call Vol Ratio 1.48
  • Today's Volume 218
  • Volume Avg (30-Day) 408
  • Put/Call OI Ratio 1.33
  • Today's Open Interest 4,771
  • Open Int (30-Day) 5,858
  • Expected Range 178.14 to 198.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.32
  • Number of Estimates 7
  • High Estimate 2.36
  • Low Estimate 2.30
  • Prior Year 2.66
  • Growth Rate Est. (year over year) -12.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
156.72 +19.97%
on 11/19/25
189.15 -0.60%
on 12/08/25
+19.96 (+11.88%)
since 11/07/25
3-Month
144.26 +30.33%
on 09/25/25
199.66 -5.83%
on 10/24/25
+26.01 (+16.06%)
since 09/08/25
52-Week
91.86 +104.67%
on 04/11/25
202.72 -7.26%
on 12/10/24
-3.80 (-1.98%)
since 12/06/24

Most Recent Stories

More News
Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know

Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know

CRL : 188.61 (+2.33%)
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

CRL : 188.61 (+2.33%)
Charles River Laboratories to Present at Evercore Healthcare Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Evercore 8 th Annual Healthcare Conference on Wednesday, December 3 rd ...

CRL : 188.61 (+2.33%)
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC (“KSF”), announces that KSF has commenced an investigation into...

CRL : 188.61 (+2.33%)
Charles River Laboratories Stock: Is Wall Street Bullish or Bearish?

Charles River Laboratories has continued to underperform the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

XLV : 151.92 (-0.87%)
$SPX : 6,839.27 (-0.45%)
CRL : 188.61 (+2.33%)
Charles River Laboratories to Present at Jefferies Global Healthcare Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 18 th , at 11:30...

CRL : 188.61 (+2.33%)
Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest

Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest

CRL : 188.61 (+2.33%)
5 Must-Read Analyst Questions From Charles River Laboratories’s Q3 Earnings Call

5 Must-Read Analyst Questions From Charles River Laboratories’s Q3 Earnings Call

CRL : 188.61 (+2.33%)
Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

GILD : 121.65 (+0.35%)
CRL : 188.61 (+2.33%)
MRNA : 27.65 (-0.18%)
AORT : 44.23 (-0.82%)
THC : 206.41 (-1.71%)
3 Healthcare Stocks We Approach with Caution

3 Healthcare Stocks We Approach with Caution

ENOV : 26.97 (-0.19%)
HSIC : 73.40 (-0.30%)
CRL : 188.61 (+2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 189.09
2nd Resistance Point 187.49
1st Resistance Point 185.90
Last Price 188.61
1st Support Level 182.72
2nd Support Level 181.12
3rd Support Level 179.53

See More

52-Week High 202.72
Last Price 188.61
Fibonacci 61.8% 160.37
Fibonacci 50% 147.29
Fibonacci 38.2% 134.21
52-Week Low 91.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar